NYSE:G

Genpact Ltd (G)

35.14
+0.73 (2.12%)
as of Sep 11, 2026, 8:00:00 pm Market Open.
1 watching
0
Investor Insights
star iconSep 12, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Genpact Ltd (G-N) has shown resilience over the years, growing its earnings at a rate of 13% over the last 15 years. Currently trading at a price-to-earnings ratio of 9.7x, the company boasts a free cash flow yield of 8.5%. Despite facing a 20% decline this year due to concerns related to artificial intelligence, the validity of these fears is disputed by some analysts. Michael O'Reilly from Stockchase has expressed concerns about the stock's performance, recommending a disciplined approach, including a stop-loss strategy. Overall, while there is recognition of Genpact's growth potential, there is also caution among experts regarding its current market position.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
WNS
BUY ON WEAKNESS
Might be a little high. Perfers in the low $20's.
PAST TOP PICK
(Was a top pick on April 10 up 7.5%) A little expensive now but they are still holding.
DON'T BUY
Will be hard to have more growth.
TOP PICK
A leader in all its products. Strong mngmnt.
DON'T BUY
Dominant in razor blades. Not a fan of mngmnt (old thinking?). Concerns on their business model. A one product company.
DON'T BUY
Management has stumbled.
Showing 16 to 21 of 21 entries